Country | |
US | 14 10,22–23,25,27,29–32,34–37,40 |
UK | 6 3,5,8,21,33,39 |
Australia | 226,28 |
Canada | 219,38 |
Malaysia | 220,24 |
|
Date study undertaken | |
2004–2009 | 11 3,8,10,20–22,24,27,30,34,37 |
2010–2014 | 8 5,19,23,31–33,35–36 |
2015–2019 | 7 25–26,28–29,38–40 |
|
Study design | |
Cross-sectional | 15 5,10,19,24–25,27–31,33,34,36,38–39 |
Non-randomised controlled trial | 5 8,23,32,37,40 |
Qualitative | 4 3,21–22,26 |
Randomised controlled trial | 220,35 |
|
Population | |
All registered patients | 17 5,19,20,22,24,27–33,35,37–40 |
Adults (>18 years old) | 4 8,10,25,34 |
Healthcare staff | 3 3,21,26 |
Children/adolescents (<21 years old) | 223,36 |
|
Healthcare system | |
Universal healthcare (UK) | 6 3,5,8,21,33,39 |
Healthcare which is a mix of government funded and private insurance (majority government funded, Canada, Australia, and Malaysia) | 6 19,20,24,26,28,38 |
Private health insurance and public health coverage (majority private insurance, US) | 14 10,22–23,25,27,29–32,34–37,40 |